Back

Deciphering the cellular tumor microenvironment landscape in salivary gland carcinomas using multiplexed imaging mass cytometry

Mayer, M.; Nachtsheim, L.; Jansen, L.; Wolber, P.; Schmiel, M.; Quaas, A.; Klussmann, J. P.; Arolt, C.

2025-05-13 otolaryngology
10.1101/2025.05.11.25327400 medRxiv
Show abstract

PurposeTo spatially characterize the single-cell tumor microenvironment (TME) of salivary gland carcinomas (SGC) and identify prognostic biomarkers. Experimental DesignSGC, including salivary duct carcinomas (SDC), acinic cell, mucoepidermoid, and secretory carcinomas, were analyzed using a 13-marker imaging mass cytometry panel. Multichannel image data from 54 primary cases and nodal metastases were processed to generate single-cell datasets. Cell phenotypes (tumor cells, cancer-associated fibroblasts (CAFs), endothelia, immune cells) were classified using a validated CAF algorithm, followed by spatial analysis and clinicopathological correlation. ResultsAmong 509,364 cells, SDC exhibited the highest fractions of Collagen-and matrix-CAFs (mCAFs). Acinic cell carcinomas (ACC) showed enriched CD4+/CD8+ T cells and antigen-presenting CAFs (apCAFs), indicating strong immune infiltration. A spatially defined cellular neighborhood (CN8) of mCAFs and endothelia was elevated in SDC, with higher CAF infiltration in androgen receptor (AR)high versus ARlow SDC. Elevated mCAF frequency and CN8 were significantly associated with reduced recurrence-free probability (RFP) and distant control rates (DCR). Additionally, higher mCAF frequencies were an independent prognostic factor for decreased RFP and DCR in Cox regression analysis. ConclusionSDC are characterized by Collagen-/mCAF-rich microenvironments and mCAF-endothelial spatial interactions that are linked to metastasis. ACC display pronounced immune infiltration, suggesting its potential for immunotherapy. mCAFs in SDC emerge as prognostic biomarkers and therapeutic targets, highlighting the importance of targeting CAF-driven metastasis in future treatments. This study provides insights into the biology of SGC and identifies novel prognostic markers.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Frontiers in Oncology
95 papers in training set
Top 0.1%
28.9%
2
Communications Medicine
85 papers in training set
Top 0.1%
20.3%
3
Frontiers in Immunology
586 papers in training set
Top 0.7%
8.8%
50% of probability mass above
4
Cancers
200 papers in training set
Top 0.7%
6.6%
5
Nature Communications
4913 papers in training set
Top 34%
4.5%
6
European Journal of Nuclear Medicine and Molecular Imaging
19 papers in training set
Top 0.1%
4.3%
7
Molecular Oncology
50 papers in training set
Top 0.2%
2.2%
8
PLOS ONE
4510 papers in training set
Top 51%
1.9%
9
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.4%
1.8%
10
Scientific Reports
3102 papers in training set
Top 56%
1.8%
11
Cells
232 papers in training set
Top 3%
1.5%
12
International Journal of Cancer
42 papers in training set
Top 0.7%
1.4%
13
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.8%
1.3%
14
The Journal of Pathology
22 papers in training set
Top 0.2%
1.3%
15
OncoImmunology
22 papers in training set
Top 0.3%
0.8%
16
Communications Biology
886 papers in training set
Top 20%
0.8%
17
iScience
1063 papers in training set
Top 28%
0.8%
18
Oncotarget
15 papers in training set
Top 0.4%
0.8%
19
Modern Pathology
21 papers in training set
Top 0.4%
0.8%
20
Signal Transduction and Targeted Therapy
29 papers in training set
Top 1%
0.8%
21
Heliyon
146 papers in training set
Top 6%
0.8%
22
Molecular & Cellular Proteomics
158 papers in training set
Top 2%
0.8%
23
Acta Neuropathologica
51 papers in training set
Top 1%
0.8%